|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001473,
umls-concept:C0017262,
umls-concept:C0022709,
umls-concept:C0034787,
umls-concept:C0036226,
umls-concept:C0185117,
umls-concept:C0332161,
umls-concept:C0520863,
umls-concept:C0680242,
umls-concept:C1144799,
umls-concept:C1524081,
umls-concept:C2911684
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1998-1-13
|
|
pubmed:abstractText |
Hypertensive cardiomyopathy is a major risk factor for the development of chronic heart failure.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin I,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin II,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin Receptor Antagonists,
http://linkedlifedata.com/resource/pubmed/chemical/Angiotensin-Converting Enzyme...,
http://linkedlifedata.com/resource/pubmed/chemical/Atrial Natriuretic Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Calcium-Transporting ATPases,
http://linkedlifedata.com/resource/pubmed/chemical/Captopril,
http://linkedlifedata.com/resource/pubmed/chemical/Dihydropyridines,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger,
http://linkedlifedata.com/resource/pubmed/chemical/Renin,
http://linkedlifedata.com/resource/pubmed/chemical/Tetrazoles
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0263-6352
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
15
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1001-9
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9321748-Angiotensin I,
pubmed-meshheading:9321748-Angiotensin II,
pubmed-meshheading:9321748-Angiotensin Receptor Antagonists,
pubmed-meshheading:9321748-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:9321748-Animals,
pubmed-meshheading:9321748-Atrial Natriuretic Factor,
pubmed-meshheading:9321748-Blotting, Northern,
pubmed-meshheading:9321748-Blotting, Western,
pubmed-meshheading:9321748-Calcium-Transporting ATPases,
pubmed-meshheading:9321748-Captopril,
pubmed-meshheading:9321748-Cardiomyopathy, Hypertrophic,
pubmed-meshheading:9321748-Diastole,
pubmed-meshheading:9321748-Dihydropyridines,
pubmed-meshheading:9321748-Disease Models, Animal,
pubmed-meshheading:9321748-Heart Ventricles,
pubmed-meshheading:9321748-Hemodynamics,
pubmed-meshheading:9321748-Hypertension,
pubmed-meshheading:9321748-Mice,
pubmed-meshheading:9321748-Mice, Transgenic,
pubmed-meshheading:9321748-Myocardium,
pubmed-meshheading:9321748-RNA, Messenger,
pubmed-meshheading:9321748-Rats,
pubmed-meshheading:9321748-Rats, Sprague-Dawley,
pubmed-meshheading:9321748-Renin,
pubmed-meshheading:9321748-Sarcoplasmic Reticulum,
pubmed-meshheading:9321748-Tetrazoles
|
|
pubmed:year |
1997
|
|
pubmed:articleTitle |
Angiotensin receptor antagonism and angiotensin converting enzyme inhibition improve diastolic dysfunction and Ca(2+)-ATPase expression in the sarcoplasmic reticulum in hypertensive cardiomyopathy.
|
|
pubmed:affiliation |
Klinik III für Innere Medizin der Universität zu Köln, Germany.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
